Indefinite Delivery Contract SPE2DR25D3943

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract has a ceiling value of $999,999,999 and a period of performance through December 31, 2036. It serves as a prime vendor arrangement to provide worldwide pharmaceutical support, including brand-name and generic drugs, specialty medications, vaccines, medical devices, and other related products, to the Department of Defense (DoD), United States Coast Guard, and other designated government agencies and healthcare programs. The procurement is an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation, and the DLA intends to make multiple primary supplier awards across different geographic regions as well as a separate backup supplier award. The IDC supports normal day-to-day operations as well as contingency, readiness, and war materiel requirements for military treatment facilities, veterans' healthcare, and other federal medical institutions globally.

The original solicitation, which is expected to be issued in March 2024, has an estimated total value of $30.3 billion over the base 30-month period and three 30-month option periods. The contract will cover pharmaceutical products listed in the 6505 stock catalog/schedule and the National Drug Code (NDC) database. Offerors will provide separate distribution fees for brand/generic and specialty drugs, and the DLA may utilize a reverse auction strategy to obtain the best possible pricing. This IDC serves as a critical mechanism for the federal government to efficiently procure essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other eligible beneficiaries worldwide.